Cargando…
Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
Background: Esophagogastric junction tumor (EGJ) is a rare but fatal disease with a rapid rising incidence worldwide in the late 20 years, and it lacks a convenient and safe method for diagnosis. The present study aimed to evaluate the potential of serum CYR61 as a biomarker for the diagnosis of EGJ...
Autores principales: | Chu, Ling-Yu, Zhou, Jian-Yuan, Zhao, Yi-Xuan, Ou, Yan-Ting, Yang, Tian, Peng, Yu-Hui, Fang, Wang-Kai, Xu, Yi-Wei, Xie, Jian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217984/ https://www.ncbi.nlm.nih.gov/pubmed/34085702 http://dx.doi.org/10.1042/BSR20204117 |
Ejemplares similares
-
Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022) -
Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma
por: Shigeoka, Manabu, et al.
Publicado: (2015) -
Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma
por: Liu, Can-Tong, et al.
Publicado: (2020) -
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018) -
Circulating Levels of L1-cell Adhesion Molecule as a Serum Biomarker for Early Detection of Gastric Cancer and Esophagogastric Junction Adenocarcinoma
por: Chu, Ling-Yu, et al.
Publicado: (2020)